Advertisement
BD Bioscience
BD Bioscience

Publisher gives authors copyright

A medical publisher has changed its copyright policy to ease the process for authors to comply with the federal public access mandate. Starting today (May 1), authors will automatically retain copyright of manuscripts submitted to Rockefeller University Press journals, according to an linkurl:editorial;http://www.jcb.org/cgi/content/full/jcb.200804037 published yesterday in the Journal of Cell Biology. Giving copyrights to authors streamlines the process of submitting articles to PubMed Centra

By | May 1, 2008

A medical publisher has changed its copyright policy to ease the process for authors to comply with the federal public access mandate. Starting today (May 1), authors will automatically retain copyright of manuscripts submitted to Rockefeller University Press journals, according to an linkurl:editorial;http://www.jcb.org/cgi/content/full/jcb.200804037 published yesterday in the Journal of Cell Biology. Giving copyrights to authors streamlines the process of submitting articles to PubMed Central within 12 months of acceptance for publication, as a federal linkurl:mandate;http://www.the-scientist.com/blog/display/54028/ passed this year requires. Under the traditional model of publishing, authors give copyrights to a journal forever. In order for authors to comply with the new mandate they have to negotiate with journals to retain copyright. While Rockefeller University Press will continue to require readers to pay for articles for six months after publication, they will now do so under a license from the author. After six months, a linkurl:creative commons;http://www.the-scientist.com/blog/display/53977/ license will take effect, which lets anyone reuse, redistribute, or publish the paper for non-commercial purposes. Rockefeller University Press, which includes The Journal of Cell Biology, The Journal of Experimental Medicine, and The Journal of General Physiology, has been a strong supporter of the National Institutes of Health linkurl:mandate;http://www.the-scientist.com/blog/display/54442/ for public access. Copyright has been a major linkurl:sticking point;http://www.the-scientist.com/blog/display/54412/ for publishers facing the new mandate. This new policy makes Rockefeller University Press journals the first subscription journals to open up all journal content under a creative commons license. "We see it that we're in an ideal position to push the bar showing people what's possible to be done," Emma Hill, executive editor of the Journal of Cell Biology told The Scientist. That is "to do the right things for scientific publishers, and meet the goals in research and academia."

Comments

Avatar of: Ad Lagendijk

Ad Lagendijk

Posts: 1

May 8, 2008

Apparently the world of medical publishing seems to be ahead. I would very much like other areas of scientific publishing to follow. Maybe researchers in those other fields should get more assertive.
Advertisement
Sterling ultracold
Sterling ultracold

Popular Now

  1. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  2. First Data from Anti-Aging Gene Therapy
  3. Brain Keeps Watch During Sleep
  4. Advances in Genome Editing
    Daily News Advances in Genome Editing

    Researchers develop a CRISPR-based technique that efficiently corrects point mutations without cleaving DNA.

Advertisement
Advertisement
RayBioTech
LI-COR Biosciences
LI-COR Biosciences